Skip to main content
Top
Literature
1.
go back to reference Diez-Perez A, Naylor KE, Abrahamsen B, Agnusdei D, Brandi ML, Cooper C, Dennison E, Eriksen EF, Gold DT, Guanabens N, Hadji P, Hiligsmann M, Horne R, Josse R, Kanis JA, Obermayer-Pietsch B, Prieto-Alhambra D, Reginster JY, Rizzoli R, Silverman S, Zillikens MC, Eastell R, Adherence Working Group of the International Osteoporosis Foundation and the European Calcified Tissue Society (2017) Recommendations for the screening of adherence to oral bisphosphonates. Osteoporos Int. doi:10.1007/s00198-017-3906-6 CrossRefPubMedPubMedCentral Diez-Perez A, Naylor KE, Abrahamsen B, Agnusdei D, Brandi ML, Cooper C, Dennison E, Eriksen EF, Gold DT, Guanabens N, Hadji P, Hiligsmann M, Horne R, Josse R, Kanis JA, Obermayer-Pietsch B, Prieto-Alhambra D, Reginster JY, Rizzoli R, Silverman S, Zillikens MC, Eastell R, Adherence Working Group of the International Osteoporosis Foundation and the European Calcified Tissue Society (2017) Recommendations for the screening of adherence to oral bisphosphonates. Osteoporos Int. doi:10.​1007/​s00198-017-3906-6 CrossRefPubMedPubMedCentral
2.
go back to reference Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, Walsh JS, Eastell R (2016) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int 27(1):21–31. doi:10.1007/s00198-015-3145-7 CrossRefPubMed Naylor KE, Jacques RM, Paggiosi M, Gossiel F, Peel NF, McCloskey EV, Walsh JS, Eastell R (2016) Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study. Osteoporos Int 27(1):21–31. doi:10.​1007/​s00198-015-3145-7 CrossRefPubMed
3.
go back to reference Baim S, Miller PD (2009) Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J Bone Miner Res 24(4):561–574. doi:10.1359/jbmr.090203 CrossRefPubMed Baim S, Miller PD (2009) Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw. J Bone Miner Res 24(4):561–574. doi:10.​1359/​jbmr.​090203 CrossRefPubMed
5.
go back to reference Shan PF, Wu XP, Zhang H, Luo XH, Cao XZ, Xie H, Liu SP, Pi YZ, Fang TY, Liu H, Chen ZH, Zhong N, Liao EY (2006) Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women. Clin Chim Acta 366(1–2):233–238. doi:10.1016/j.cca.2005.10.009 CrossRefPubMed Shan PF, Wu XP, Zhang H, Luo XH, Cao XZ, Xie H, Liu SP, Pi YZ, Fang TY, Liu H, Chen ZH, Zhong N, Liao EY (2006) Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women. Clin Chim Acta 366(1–2):233–238. doi:10.​1016/​j.​cca.​2005.​10.​009 CrossRefPubMed
6.
go back to reference Iki M, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H, Group JS (2004) Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese population-based osteoporosis (JPOS) study. Osteoporos Int 15(12):981–991. doi:10.1007/s00198-004-1634-1 CrossRefPubMed Iki M, Akiba T, Matsumoto T, Nishino H, Kagamimori S, Kagawa Y, Yoneshima H, Group JS (2004) Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese population-based osteoporosis (JPOS) study. Osteoporos Int 15(12):981–991. doi:10.​1007/​s00198-004-1634-1 CrossRefPubMed
7.
go back to reference Filip RS, Zagorski J (2004) Age- and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin region, Poland. Ann Agric Environ Med 11(2):255–259PubMed Filip RS, Zagorski J (2004) Age- and BMD-related differences in biochemical markers of bone metabolism in rural and urban women from Lublin region, Poland. Ann Agric Environ Med 11(2):255–259PubMed
8.
go back to reference Bell KJ, Hayen A, Irwig L, Hochberg MC, Ensrud KE, Cummings SR, Bauer DC (2012) The potential value of monitoring bone turnover markers among women on alendronate. J Bone Miner Res 27(1):195–201. doi:10.1002/jbmr.525 CrossRefPubMed Bell KJ, Hayen A, Irwig L, Hochberg MC, Ensrud KE, Cummings SR, Bauer DC (2012) The potential value of monitoring bone turnover markers among women on alendronate. J Bone Miner Res 27(1):195–201. doi:10.​1002/​jbmr.​525 CrossRefPubMed
9.
go back to reference Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K (2008) Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosis. Endocr J 55(1):41–48CrossRefPubMed Majima T, Shimatsu A, Komatsu Y, Satoh N, Fukao A, Ninomiya K, Matsumura T, Nakao K (2008) Association between baseline values of bone turnover markers and bone mineral density and their response to raloxifene treatment in Japanese postmenopausal women with osteoporosis. Endocr J 55(1):41–48CrossRefPubMed
Metadata
Title
Comments on Diez-Perez et al.: Recommendations for the screening of adherence to oral bisphosphonates
Authors
Y. H. Zhou
Z. F. Sheng
Publication date
01-07-2017
Publisher
Springer London
Published in
Osteoporosis International / Issue 7/2017
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-017-3987-2

Other articles of this Issue 7/2017

Osteoporosis International 7/2017 Go to the issue